No Data
No Data
Press Release: Syros to Report Second Quarter 2024 Financial Results on Wednesday, July 31, 2024
Syros to Report Second Quarter 2024 Financial Results on Wednesday, July 31, 2024
Syros (SYRS) Stock Rises More Than 35% in 3 Months: Here's Why
Syros Pharmaceuticals(SYRS.US) Director Sells US$178.37K in Common Stock
Form 144 | Syros Pharmaceuticals(SYRS.US) Director Proposes to Sell 199.27K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 28, $Syros Pharmaceuticals(SYRS.US)$ Director Young Richard A intends to sell 34,837 shares of its common stock on Jun 28, with a total market value of approximately $199.2
TD Cowen Maintains Syros Pharmaceuticals(SYRS.US) With Buy Rating
No Data